The Uromigos
104 FOLLOWERS
Broadcasting the latest developments in GU cancer
The Uromigos
1w ago
Michiel Van der Heijden explores the role of radiotherapy and other neoadjuvant and other neoadjuvant combinations to prevent the need for surgery ..read more
The Uromigos
2w ago
Matt Galsky describes his phase 2 study looking at gem/cis/nivo followed by nivo in responders. This potentially avoids cystectomy ..read more
The Uromigos
1M ago
FDA Deputy Oncology Director Dan Suzman described approaches to oncology trials. Tom asks 3 last questions which annoys Brian more than usual ..read more
The Uromigos
1M ago
Tanya Dorff describes acapatamab, a prostate-specific membrane antigen (PSMA) CD3 bispecific engager ..read more
The Uromigos
1M ago
Michael Lattanzi discusses treatment plans and research in the community ..read more
The Uromigos
2M ago
Vania Wisdom, editor of the Lancet, talks about approaches to cancer treatment and research in developing countries ..read more
The Uromigos
2M ago
David McDermott discusses melanoma and renal data. We never get to bladder or lung ..read more
The Uromigos
2M ago
Dana Rathkopf describes phase 1 data for the androgen receptor ligand-directed degrader in prostate cancer ..read more